JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M304363200 on August 13, 2003

J. Biol. Chem., Vol. 278, Issue 44, 43363-43372, October 31, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/44/43363    most recent
M304363200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawagoe, J.
Right arrow Articles by Kurachi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawagoe, J.
Right arrow Articles by Kurachi, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Raloxifene Inhibits Estrogen-induced Up-regulation of Telomerase Activity in a Human Breast Cancer Cell Line*

Jun Kawagoe{ddagger}, Masahide Ohmichi{ddagger}¶||, Toshifumi Takahashi{ddagger}, Chika Ohshima**, Seiji Mabuchi¶, Kazuhiro Takahashi{ddagger}, Hideki Igarashi{ddagger}, Akiko Mori-Abe{ddagger}, Maki Saitoh{ddagger}, Botao Du{ddagger}, Tsuyoshi Ohta{ddagger}§, Akiko Kimura¶, Satoru Kyo§, Masaki Inoue§, and Hirohisa Kurachi{ddagger}

From the {ddagger}Department of Obstetrics and Gynecology and the **Division of Nursing, Yamagata University, School of Medicine, 2-2-2 Iidanishi, Yamagata 990-9585, Japan, the Department of Obstetrics and Gynecology, Osaka University Medical School, 2-2, Yamadaoka, Suita, Osaka 565-0871, Japan, and the §Department of Obstetrics and Gynecology, Kanazawa University Medical School, 13-1, Takaramachi Kanazawa-shi, Ishikawa 920-8640, Japan

The mechanism by which raloxifene acts in the chemoprevention of breast cancer remains unclear. Because telomerase activity is involved in estrogen-induced carcinogenesis, we examined the effect of raloxifene on estrogen-induced up-regulation of telomerase activity in MCF-7 human breast cancer cell line. Raloxifene inhibited the induction of cell growth and telomerase activity by 17{beta}-estradiol (E2). Raloxifene inhibited the E2-induced expression of the human telomerase catalytic subunit (hTERT), and transient expression assays using luciferase reporter plasmids containing various fragments of the hTERT promoter showed that the estrogen-responsive element appeared to be partially responsible for the action of raloxifene. E2 induced the phosphorylation of Akt, and pretreatment with a phosphatidylinositol 3-kinase (PI3K) inhibitor, LY294002, attenuated the E2-induced increases of the telomerase activity and hTERT promoter activity. Raloxifene inhibited the E2-induced Akt phosphorylation. In addition, raloxifene also inhibited the E2-induced hTERT expression via the PI3K/Akt/NF{kappa}B cascade. Moreover, raloxifene also inhibited the E2-induced phosphorylation of hTERT, association of NF{kappa}B with hTERT, and nuclear accumulation of hTERT. These results show that raloxifene inhibited the E2-induced up-regulation of telomerase activity not only by transcriptional regulation of hTERT via an estrogen-responsive element-dependent mechanism and the PI3K/Akt/NF{kappa}B cascade but also by post-translational regulation via phosphorylation of hTERT and association with NF{kappa}B.


Received for publication, April 25, 2003 , and in revised form, August 12, 2003.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Dept. of Obstetrics and Gynecology, Yamagata University, School of Medicine, 2-2-2 Iidanishi, Yamagata 990-9585, Japan. Tel.: 81-23-628-5393; Fax: 81-23-628-5396; E-mail: masa{at}med.id.yamagata-u.ac.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
V. M. Miller and S. P. Duckles
Vascular Actions of Estrogens: Functional Implications
Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Kawagoe, M. Ohmichi, S. Tsutsumi, T. Ohta, K. Takahashi, and H. Kurachi
Mechanism of the Divergent Effects of Estrogen on the Cell Proliferation of Human Umbilical Endothelial Versus Aortic Smooth Muscle Cells
Endocrinology, December 1, 2007; 148(12): 6092 - 6099.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
S. BAYNE, M. E.E. JONES, H. LI, and J.-P. LIU
Potential Roles for Estrogen Regulation of Telomerase Activity in Aging
Ann. N.Y. Acad. Sci., October 1, 2007; 1114(1): 48 - 55.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Doshida, M. Ohmichi, S. Tsutsumi, J. Kawagoe, T. Takahashi, B. Du, A. Mori-Abe, T. Ohta, M. Saitoh-Sekiguchi, K. Takahashi, et al.
Raloxifene Increases Proliferation and Up-regulates Telomerase Activity in Human Umbilical Vein Endothelial Cells
J. Biol. Chem., August 25, 2006; 281(34): 24270 - 24278.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Kirschenbaum, X.-H. Liu, S. Yao, G. Narla, S. L. Friedman, J. A. Martignetti, and A. C. Levine
Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones
Carcinogenesis, February 1, 2006; 27(2): 216 - 224.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Saitoh, M. Ohmichi, K. Takahashi, J. Kawagoe, T. Ohta, M. Doshida, T. Takahashi, H. Igarashi, A. Mori-Abe, B. Du, et al.
Medroxyprogesterone Acetate Induces Cell Proliferation through Up-Regulation of Cyclin D1 Expression via Phosphatidylinositol 3-Kinase/Akt/Nuclear Factor-{kappa}B Cascade in Human Breast Cancer Cells
Endocrinology, November 1, 2005; 146(11): 4917 - 4925.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Bjornstrom and M. Sjoberg
Mechanisms of Estrogen Receptor Signaling: Convergence of Genomic and Nongenomic Actions on Target Genes
Mol. Endocrinol., April 1, 2005; 19(4): 833 - 842.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
B. Du, M. Ohmichi, K. Takahashi, J. Kawagoe, C. Ohshima, H. Igarashi, A. Mori-Abe, M. Saitoh, T. Ohta, A. Ohishi, et al.
Both estrogen and raloxifene protect against {beta}-amyloid-induced neurotoxicity in estrogen receptor {alpha}-transfected PC12 cells by activation of telomerase activity via Akt cascade
J. Endocrinol., December 1, 2004; 183(3): 605 - 615.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.